Evaluating IWG Response Criteria for MDS Patients | Jan Bewersdorf, MD | ASH 2023

Evaluating IWG Response Criteria for MDS Patients | Jan Bewersdorf, MD | ASH 2023
Costs & Financial Hardship Among BMT CTN 1102 Patients MDS | Christopher Su, MD | ASH 2023
Exploring Drug Options for MDS Patients with XPO1 Inhibitors | Justin Taylor, MD & Sana Chaudhry, BS | ASH 2023
What You Need To Know About MDS-U, The Type With No Classification

The Promising Treatment Of Imetelstat And Transfusion Independence
